Recent advances in hepatitis B vaccination

Hepatitis B Annual

Volumn 5, Issue 1, 2008, Pages 51-65

  Madalinski, Kazimierz ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Anti HBs; DNA vaccines; Edible vaccines; Hepatitis B surface antigen (HBsAg); Hepatitis B virus (HBV); Immunization; Immunogenicity; Pre S1 antigen; Vaccine

Indexed keywords

DNA VACCINE; GEN H B VAX; H B VAX II; H B VAX PRO; HEPA GENE 3; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPAVAX GENE; HEPIMMUNE; LAMIVUDINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY RESPONSE; CANCER INCIDENCE; CANCER PREVENTION; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RATE; LIVER CELL CARCINOMA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; STRAIN DIFFERENCE; TREATMENT RESPONSE; VACCINATION; VACCINE PRODUCTION; VIRUS IMMUNITY; VIRUS TRANSMISSION;

EID: 77953464673     PISSN: 09729747     EISSN: 19983573     Source Type: Journal    
DOI: 10.4103/0972-9747.58805     Document Type: Review

References (43)

1. Cianciara J. Viral hepatitis B. In: Cianciara J, Juszczyk J. editors. Infectious and parasitic diseases (in Polish). Lublin, Poland: Czelej Publishing House; 2007.
2. http://www.who.int/mediacentre/factsheets/fs204/en/index.html [Accessed 16 March 2008].
3. Dzierżanowska-Fangrat K. Infections caused by hepatotropic viruses: HBV and HCV-epidemiology, pathogenesis and treatment. Post Microbiol 2001;40:151-169
4. Kao JH. Hepatitis B viral genotypes: Clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002;17:643-650
5. Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus (HBV) genotype Influence the clinical outcome of HBV infection? J Viral Hepatol 1999;6:299-304.
6. Dzierżanowska-Fangrat K, Woynarowski M, Szczygielska I, Jozwiak P, Cielecka-Kuszyk J, Dzierzanowska D, et al. Hepatitis B virus genotypes in children with chronic hepatitis B in Poland. Eur J Gastr Hepatol 2006;18:655-658
7. Madaliński K, Zychowicz C, Gornicki J. Immunogenicity of recombinant hepatitis B vaccine containing S, pre-S1, pre-S2 antigens in children: Persistence of antibodies. Centr Eur J Immunol 1994;19:333-338
8. Raz R, Koren R, Bass D. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in adults. Isr Med Assoc J 2001;3:328-332
9. Madalinski K, Sylvan PE, Hellstrom U, Mikolajewicz J, Zembrzuska-Sadkowska E, Piontek E. Antibody responses to preS components after immunization of children with low doses of BioHepB. Vaccine 2002;20:92-95
10. Shapira MY, Zeira E, Adler R, Shouval D. Rapid seroprotection against hepatitis B following the first dose of pre-S1/pre-S2/S vaccine. J Hepatol 2001;34:123-127
11. Madalinski K, Sylvan PE, Hellstrom U, Mikołajewicz J, Dzierzanowska-Fangrat K. Presence of anti-preS1, antipreS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-BTM vaccine. Med Sci Monit 2004;10:PI10-7.
12. Banatvala J, van Damme P, Oehen S. Lifelong protection against hepatitis B: The role of vaccine immunogenicity in immune memory. Vaccine 2001;19:877-885
13. Banatvala J, van Damme P. Hepatitis B vaccine: Do we need boosters? J Viral Hepat 2003;10:1-6.
14. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13:S47-9.
15. Kane MA. World-wide status of hepatitis B vaccination 1998. Soz Präventivmed 1998;43:S44-6,S118-20.
16. Magdzik W. Vaccination against hepatitis B and epidemiological situation of this disease in European countries in the years 1990-2001. Przegl Epidemiol 2006;60:179-184
17. Gesemann M, Scheiermann N. Quantitation of hepatitis B-induced antibodies as a predictor of anti-HBs persistence. Vaccine 1995;13:443-447
18. Bauer T, Jilg W. Hepatitis B surface antigen-specifi c T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006;24:572-577
19. Saffar MJ, Rezai MS. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. Indian Pediatr 2004;41:1232-1237
20. Fitzsimons D, Francois G, Hall A, McMahon B, Meheus A, Zanetti A, et al. Long-term efficacy of hepatitis B vaccine, booster policy and impact of hepatitis B virus. Vaccine 2005;23:4158-4166 (Pubitemid 40814591)
21. Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, et al. Long-term persistence of anti-HBs after vaccination against HBV: An 18 year experience in health care workers. Vaccine 2004;22:607-610
22. Wang RX, Boland GJ, van Hattum J, de Gast GC. Long term persistence of T cell memory to HBsAg after hepatitis B vaccination. World J Gastroenterol 2004;10:260-263
23. Bauer T, Jilg W. Hepatitis B surface antigen-specifi c T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006;24:572-577
24. Basuni AA, Carman WF. HBV vaccine-escape variants. Methods Mol Med 2004;95:115-124
25. Tabor E. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol 2006;78:S43-7.
26. Velu V, Saravanan S, Nandakumar S, Dhevahi E, Shankar EM, Murugavel KG, et al. Transmission of 'a' determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers. Jpn J Infect Dis 2008;61:73-76
27. Wilson JN, Nokes DJ, Medley GF, Shouval D. Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules. Vaccine 2007;25:3705-3712
28. Zuckerman JN, Zuckerman AJ. Recombinant hepatitis B triple antigen vaccine: Hepacare. Expert Rev Vaccines 2002;1:141-144
29. Rendi-Wagner P, Shouval D, Genton B, Lurie Y, Rümke H, Boland G, et al. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non-and low responders to conventional vaccine. Vaccine 2006;24:2781-2789
30. Flint SJ. Transformation and oncogenesis. Principles of Virology 2004. p. 654-700.
31. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007;13:74-78
32. Hassan MM, Frome V, Patt YZ, El-Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002;35:266-269
33. Rapits I, Koskinas J, Emmanouil T, Hadziyannis S. Changing relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in Greece: Epidemiological and clinical observations. J Viral Hepat 2003;10:450-454
34. Roy MJ, Wu MS, Barr LJ, Fuller JT, Tussey LG, Speller S, et al. Induction of antigen-specifi c CD8 + T cells, T helper cells, and protective levels of antibody in humans by particlemediated administration of a hepatitis B virus DNA vaccine. Vaccine 2001;19:764-778
35. Tacket CO, Roy MJ, Widera G, Swain WF, Broome S, Edelman R. Phase 1 safety and immune response studies of DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 1999;17:2826-2829
36. Rottinghaus ST, Poland GA, Jacobson RM, Barr LJ, Roy MJ. Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 2003;21:4604-4608
37. Thermet A, Rollier Ch, Zoulim F, Trepo C, Cova L. Progress in DNA vaccine for prophylaxis and therapy of hepatitis B. Vaccine 2003;21:659-662
38. Koprowski H. Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants. Arch Immunol Ther Exp 2002;50:365-369
39. Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y, et al. Virus-like particle expression and assembly in plants: Hepatitis B and Norwalk viruses. Vaccine 2005;23:1851-1858
40. Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letellier M, Lisowa O, et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J 1999;13:1796-1799
41. Pniewski T, Kapusta J, Płucienniczak A. Agrobacteriummediated transformation of yellow lupin to generale callus tissue producing HBV surface antigen in a long-term culture. J Appl Genet 2006;47:309-318
42. Toward a banana-based vaccine for hepatitis B. Science Daily, May 1, 2007.
43. Sunil Kumar GB, Ganapathi TR, Bapat VA. Production of hepatitis B surface antigen in recombinant plant systems: An update. Biotechnol Prog 2007;23:532-539